share_log

Ascendis Pharma Shares Are Trading Higher After Evercore ISI Raised Its Price Target on the Stock From $220 to $260.

Benzinga ·  Feb 18 20:29
Ascendis Pharma Shares Are Trading Higher After Evercore ISI Raised Its Price Target on the Stock From $220 to $260.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 274

Recommended

Write a comment